Option 1
Danaher—
I’m reaching out to you out of concern for the millions of people living with dangerous diseases who do not receive a diagnosis. Your GeneXpert machines can diagnose Ebola, HIV, extensively drug-resistant TB, hepatitis, and many common sexually transmitted infections, but they are out of reach to the people who need them most because of unreasonably high prices.
Independent research has shown that you can make a fair profit at $5 per test, which would allow governments and organizations to scale up testing. These tests currently cost $15-$20, which is too expensive for many who need them. Millions of people continue to die of treatable diseases and your tests could help change that.
In September of last year, you made a commitment to have the actual cost of your MTR/RIF Xpert cartridges validated with a third-party assessment, and to release these results publicly. Over a year later, this still has not happened. All research available continues to show that your tests are sold for far above the cost to produce them.
I urge you to show your commitment to putting people over profits by fulfilling your promise to annually audit TB test prices. I ask that you release the results of the audit by October 14th, 2024.
Regards,
[Your name]